Radiation-induced Esophagitis Epidemiology Forecast to 2030

Radiation-induced Esophagitis Epidemiology Forecast to 2030

  • July 2020 •
  • 100 pages •
  • Report ID: 5932737 •
  • Format: PDF
‘Radiation-induced Esophagitis- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted radiation-induced esophagitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2017–2030

Radiation-induced Esophagitis: Understanding

The radiation-induced esophagitis (RIE) epidemiology report gives a thorough understanding of the RIE by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for RIE in the US, Europe, and Japan. Moreover, the report covers the detailed information of the radiation-induced esophagitis epidemiology scenario in seven major countries (US, EU5, and Japan).

Epidemiology Perspective:

This section encompassing radiation-induced esophagitis (RIE) epidemiology provides insights about historical and current patient pool and forecasted trend for every seven major countries. The RIE epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Detailed Epidemiology Segmentation:

The radiation-induced esophagitis epidemiology covered in the report provides historical as well as forecasted RIE epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.
The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

• The radiation-induced esophagitis (RIE) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The RIE report and model provide an overview of the global trends of RIE in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into the historical and forecasted patient pool of RIE in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of radiation-induced esophagitis.

• The report provides the segmentation of the Radiation-induced Esophagitis epidemiology

Report Highlights:

• 11-year Forecast of Radiation-induced Esophagitis Epidemiology
• 7MM Coverage
• Incidence of Lung Cancer by Types
• Stage-wise Incidence of NSCLC
• Cases receiving CCRT/CRT
• Acute Radiation-induced Esophagitis (ARIE) by Grade

KOL – Views:

We interview KOLs and include SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. It will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered:
• What will be the growth opportunities in the 7MM concerning the patient population pertaining to radiation-induced esophagitis (RIE)?
• What are the key findings pertaining to the radiation-induced esophagitis (RIE) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017–2030)?
• What would be the total number of patients of radiation-induced esophagitis (RIE) across the 7MM during the forecast period (2017–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2030)?
• What is the disease risk, burden and unmet needs of radiation-induced esophagitis (RIE)?
• What are the currently available treatments of radiation-induced esophagitis (RIE)?

Reasons to buy:
The radiation-induced esophagitis (RIE) Epidemiology report will allow the user to:
• Develop business strategies by understanding the trends shaping and driving the global radiation-induced esophagitis (RIE) market.
• Quantify patient populations in the global radiation-induced esophagitis (RIE) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for radiation-induced esophagitis (RIE) therapeutics in each of the markets covered

• Understand the magnitude of radiation-induced esophagitis (RIE) population by its epidemiology
• The radiation-induced esophagitis (RIE) Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments:
• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population